Key result
Tumour grading predicts prognosis better than site or size in primary lung sarcomas with 28-month survival.
Why the study?
Primary sarcomas of the lung are rare and their clinicopathological and immunohistochemical features require detailed characterization.
Observational (n=14)
No
In primary sarcomas of the lung, tumour grading appears to be a more useful prognostic factor than tumour site or size, with an overall survival of 28 months.
Answers are grounded in this paper and cite their sources.
Tumour grading may aid prognosis over site or size in primary lung sarcomas; hypothesis-generating and requires validation in larger cohorts.
The clinicopathological features and immunohistochemical findings in 14 primary sarcomas of the lung collected over a 30-year-period are presented. This represents one sarcoma per 550 bronchogenic carcinomas undergoing resection in this centre. The study group comprised six leiomyosarcomas, five malignant peripheral nerve sheath tumours, two haemangiopericytomas and one epithelioid haemangioendothelioma. The majority of cases occurred in men (nine males: five females), with mean age at presentation of 54 years for men and 47 years for women. All leiomyosarcomas were seen in men, whereas malignant peripheral nerve sheath tumours showed no particular sex preponderance. Leiomyosarcomas were larger tumours than malignant peripheral nerve sheath tumours, mean tumour diameter 15 cm (range 10-25 cm) compared to 9.5 cm (7-15 cm), respectively. All leiomyosarcomas were situated intraparenchymally whereas two of the five malignant peripheral nerve sheath tumours were endobronchial in site. Extrathoracic metastates were seen at death in two of the six leiomyosarcomas but not in any of the malignant peripheral nerve sheath tumours. Overall survival was 28 months although for the leiomyosarcoma/malignant peripheral nerve sheath tumour group alone survival was 8 months. Tumour grading appeared to be a more useful prognostic factor than tumour site (endobronchial/parenchymal) or tumour size. Haemangiopericytoma and epithelioid haemangioendothelioma were associated with a more favourable prognosis.
No takes yet. Share an insight, caveat, or question.
Attanoos et al. (1996) conducted an observational in Primary sarcomas of the lung (n=14). Tumour characteristics (grading, site, size) was evaluated on Overall survival. Among 14 patients with primary lung sarcomas, overall survival was 28 months, and tumour grading appeared to be a more useful prognostic factor than tumour site or size.
Synapse has enriched 10 related papers. Consider them for comparative context: